Share chart Amicus Therapeutics, Inc.
Extended chart
Simple chart
About Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc., биотехнологическая компания, занимается открытием, разработкой и коммерциализацией методов лечения целого ряда редких и орфанных заболеваний. Компания предлагает Галафолд, перорально вводимый фармакологический компаньон с малой молекулой для лечения болезни Фабри. Он также проводит фазу 3 (ATB200-03) клинического исследования AT-GAA для болезни Помпе. Компания имеет соглашения о сотрудничестве и лицензии с Национальной детской больницей и Университетом Пенсильвании. Amicus Therapeutics, Inc. была основана в 2002 году со штаб-квартирой в Крэнбери, штат Нью-Джерси.IPO date | 2007-05-31 |
---|---|
ISIN | US03152W1099 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://amicusrx.com |
Цена ао | 8.89 |
Change price per day: | 0% (8.89) |
---|---|
Change price per week: | -1.44% (9.02) |
Change price per month: | -7.11% (9.57) |
Change price per 3 month: | -12.41% (10.15) |
Change price per half year: | -21.33% (11.3) |
Change price per year: | -24.72% (11.81) |
Change price per 3 year: | -5.43% (9.4) |
Change price per 5 year: | -42.12% (15.36) |
Change price per 10 year: | -21.95% (11.39) |
Change price per year to date: | -9.29% (9.8) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Vanguard Group Inc | 28492486 | 9.65 |
Perceptive Advisors LLC | 28057456 | 9.5 |
Avoro Capital Advisors LLC | 27400000 | 9.28 |
Blackrock Inc. | 22988139 | 7.78 |
JP Morgan Chase & Company | 17848531 | 6.04 |
Wellington Management Group, LLP | 15190024 | 5.14 |
Redmile Group, LLC | 14828321 | 5.02 |
Morgan Stanley | 13327897 | 4.51 |
State Street Corporation | 13163085 | 4.46 |
William Blair Investment Management, LLC | 11647026 | 3.94 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Bradley L. Campbell M.B.A. | CEO, President & Director | 984.09k | 1976 (49 years) |
Ms. Ellen S. Rosenberg | Chief Legal Officer & Corporate Secretary | 733.94k | 1963 (62 years) |
Ms. Samantha Prout | Chief Accounting Officer & Controller | N/A | 1978 (47 years) |
Andrew Faughnan | Senior Director of Investor Relations | N/A | |
Mr. David M. Clark | Chief People Officer | 701.39k | 1976 (49 years) |
Dr. Jill Weimer Ph.D. | Chief Science Officer | N/A | |
Mr. Simon Nicolas Reade Harford | Chief Financial Officer | N/A | 1960 (65 years) |
Mr. Patrik S. Florencio Esq. | Global Chief Compliance & Risk Officer | N/A | |
Ms. Diana Moore | Head of Global Corporate Communications | N/A | |
Dr. Jeffrey P. Castelli Ph.D. | Chief Development Officer | 1972 (53 years) |
Address: United States, Philadelphia, PA , 3675 Market Street - open in Google maps, open in Yandex maps
Website: http://amicusrx.com
Website: http://amicusrx.com